Withdrawal from multiple substances in Switzerland needs a coordinated clinical assessment before a sequence of changes is agreed. The immediate question is which risks require attention now, which treatments should continue, and which setting can manage the combination. A separate online taper or detox plan for each substance cannot safely answer those questions.
If alcohol, benzodiazepines, or GHB or GBL dependence may be present, seek medical advice before abruptly stopping. For seizures, serious breathing difficulty, collapse, severe confusion, or immediate danger to life, call 144. A routine treatment booking should not delay emergency care.
Build one history that includes every substance
Prepare a single account of prescribed medicines, nonprescribed medicines, alcohol, recreational drugs, and other products. For each, explain the usual pattern, recent changes, last use, and what happens when use is delayed. Include occasional use if it could overlap with the planned withdrawal period.
A person may describe alcohol as the main problem while also taking a regular sedative or using opioids intermittently. Those additional exposures can change the assessment even if the person does not consider them addictions. The clinician needs to know what the body is currently exposed to, not only the problem named on an inquiry form.
For medicines labeled as needed, describe how often you actually take them. Also explain prescriptions from other clinicians, medication obtained abroad, and products borrowed from someone else. A list of names without the real pattern can conceal regular exposure. If memory is incomplete, a prescriber or pharmacy record may help the team reconstruct the history with your participation.
Infodrog’s work on mixed substance use highlights the importance of considering combinations and medication use. Our polysubstance use guide explains the wider assessment of patterns, harms, and treatment goals.
Distinguish dependence from the fact of using several products
Using more than one substance does not automatically mean that every substance requires withdrawal treatment. Some medicines may remain necessary, while other products need review or a supervised change. The clinician should distinguish regular physical dependence, harmful use, interactions, and separate medical indications.
The joint benzodiazepine tapering guideline distinguishes physical dependence from a substance use disorder. That distinction is useful when a prescribed medicine appears in a complex history: difficulty stopping does not by itself determine the diagnosis or the right response.
Ask the team to explain its working understanding of each substance. A useful assessment does not simply label the entire medication list as addiction. It identifies what should change, what should remain stable, and which clinician is responsible for each decision.
Identify dangerous withdrawal before arranging the rest
NHS guidance on alcohol dependence warns that abrupt cessation can cause dangerous withdrawal. The FDA gives a similar warning about abrupt benzodiazepine discontinuation or rapid reduction, including the risk of seizures.
Infodrog describes rapidly developing GHB or GBL withdrawal that may become severe. Tell the assessing service specifically about these substances, previous withdrawal complications, and any current symptoms. Do not assume the risk is low because the planned clinic specializes in a different drug.
The first clinical step may therefore be urgent stabilization rather than immediate entry into a longer rehabilitation program. Ask who will arrange the appropriate assessment and how information will reach the next service. The order should follow current needs, not the order in which packages are available.
Agree on the sequence instead of changing everything at once
The UK clinical alcohol guidelines recognize that some patients continue prescribed treatment while undergoing alcohol withdrawal, while others require management of withdrawal from additional substances. This illustrates why combined withdrawal requires a deliberate clinical plan rather than a universal all-at-once approach.
Ask which change is being made first, why that order was selected, and what will be monitored before the next decision. Some elements may happen together; others may need to be staged. The explanation should be specific to the substances, current health, and setting.
If several clinicians are involved, identify who coordinates the sequence. You should not have to decide between conflicting instructions from a GP, psychiatrist, addiction clinician, and admissions team. Ask them to reconcile the plan directly and provide one current set of instructions.
Protect established opioid treatment
The FOPH describes opioid agonist treatment as an established Swiss treatment with specific prescribing and dispensing arrangements. Its presence in a medication list does not mean it should automatically be withdrawn as part of a general detox package.
Give the receiving service the existing prescriber’s and pharmacy’s details. Confirm whether treatment can continue, how the regimen will be verified, and who will manage the first prescription after transfer. Tell the team about missed doses and any additional opioid use.
Our opioid agonist treatment guide covers the Swiss framework. If a service cannot support the required regimen, that limitation should be resolved before admission rather than discovered when the next dose is due.
Match the care setting to the combined complexity
The UK inpatient withdrawal guidance distinguishes specialist units able to manage severe or complex withdrawal from residential settings with more limited clinical capability. Its staffing rules apply to that guidance’s context, but the underlying comparison is relevant: accommodation and medical capacity are separate questions.
Ask what the proposed Swiss setting can manage overnight, how deterioration is recognized, and how urgent transfer to a hospital is arranged. Explain significant physical illness, pregnancy, cognitive difficulties, psychiatric symptoms, or previous severe withdrawal. These may change the care setting.
Our hospital and residential care comparison helps clarify the distinction. A clinically appropriate referral to a more capable service is useful information, even when it means postponing a preferred residential setting.
Consider an integrated Swiss pathway
Psychiatrische Dienste Aargau’s acute addiction and dual-diagnosis service in Windisch treats adults aged 18–64 who need intensive support because of substance dependence and serious psychiatric complexity or acute risk. Its published model includes withdrawal or stabilization, treatment of accompanying conditions, and aftercare planning.
The service also describes the possibility of opioid substitution treatment continuing in outpatient care. This is an example of an integrated pathway rather than a recommendation that every person with multiple substance use needs that particular unit. Suitability and admission must be confirmed clinically.
For residents elsewhere, ask the GP or regional addiction service which local team can coordinate the relevant problems. A complex history may need joint work across services; the important point is that someone accepts responsibility for connecting them.
Track symptoms without assigning the cause yourself
Tell the team when a symptom began, what changed beforehand, and how it affects functioning. Sleep disturbance, anxiety, low mood, agitation, or nausea may have several possible explanations in a mixed history. The timing and progression are useful observations; a self-diagnosis is less useful.
If the clinician recommends a brief record, note medication changes, symptoms, sleep, and relevant events. Keep it simple enough to maintain during a difficult period. Use the information at review rather than to calculate additional doses or alter the agreed plan.
Ask which symptoms require urgent contact and which can be discussed at the next scheduled review. The plan should make room for uncertainty and reassessment. A change in the working diagnosis can reflect better information rather than a failure of care.
Reconcile medication at every transfer
Patient Safety Switzerland emphasizes systematic medication reconciliation at admission, transfer, and discharge. The process compares the actual medication history with new instructions so that omissions, unintended additions, and other discrepancies can be addressed.
Ask for a list that clearly shows what continues, what changed, what stopped, and why. Include the next review date for temporary medicines. If two lists disagree, ask a clinician or pharmacist to resolve the difference before following an uncertain instruction.
For example, a medicine used briefly during hospital withdrawal should not be carried forward indefinitely because an old list remained in a bag. Conversely, a long-term treatment should not disappear because the receiving team only received the detox prescription.
Keep practical support realistic
Discuss safe accommodation, transport, meals, caregiving, and access to appointments. If a plan depends on a relative being present, confirm that the person can and wants to provide the agreed support. A family member should not be assigned clinical monitoring that belongs to trained staff.
If the home environment is unstable or substances are readily present, tell the team. This may change the support required during and after withdrawal. Practical difficulties are clinical planning information, not evidence that a person is insufficiently committed to treatment.
Ask for help with one concrete obstacle at a time. Arranging transport to a daily appointment or confirming a place to stay may be more immediately useful than a long list of broad recovery goals.
Leave with a continuing treatment plan
Confirm the next clinician, appointments, medication supply, and urgent contact route before discharge. If several conditions remain active, identify how the receiving clinicians will communicate. The handoff should explain unfinished work as well as what improved during the stay.
Our detox-to-rehab transition guide covers the next stage. Combined withdrawal is successful as a care process when it leads into coherent ongoing treatment, with no expectation that every substance, diagnosis, and practical problem must be resolved at the same moment.